BIO-TECHNE CORPORATION (TECH) scores 74 out of 100 on boothcheck's 11-model valuation framework. Verdict: Fair The estimated fair value is 19.74, representing a 63% premium to fair value. Quantitative score: 69/100. Qualitative score: 90/100.
Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.